357 Results (Page 11 of 15)
Indonesia Markets Research Reports
Indonesia Coronary Stents Market Analysis
Indonesia's Coronary Stents Market is expected to witness growth from $68 Mn in 2022 to $98 Mn in 2030 with a CAGR of 4.75% for the forecasted year 2022-30. The older population in Indonesia is expanding and is more likely to acquire coronary heart disease. The need for coronary stents is anticipated to rise as the senior population continues to rise. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include PT. Graha Farma, PT. Mensa Bina Sukses, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
Indonesia Contraceptive Devices Market Analysis
Indonesia's Contraceptive Devices Market is expected to witness growth from $77 Mn in 2022 to $143 Mn in 2030 with a CAGR of 8.00% for the forecasted year 2022-30. By 2050, the population of Indonesia is going to increase to 305 million from its current size. The need for contraceptive devices is anticipated to rise along with the population. The market is segmented by type and by gender. Some key players in this market include DKT Indonesia, Kimia Farma, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, and Teva Pharmaceutical.
Indonesia Blockchain Technology in Healthcare Market Analysis
This report presents a strategic analysis of the Indonesia Blockchain Technology in the Healthcare Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Blockchain Technology in the Healthcare Market, offering unmatched value, accuracy, and expert insights.
Indonesia Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of the Indonesia Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the Indonesia Advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
Indonesia Over The Counter (OTC) Pharmaceuticals Market Analysis
Indonesia's over-the-counter (OTC) pharmaceuticals market size was valued at $825 Mn in 2022 and is estimated to expand at a CAGR of 5.54% from 2022 to 2030 and will reach $1270 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
Indonesia Cancer Immunotherapy Market Analysis
Indonesia's cancer immunotherapy market is expected to grow from $675 Mn in 2022 to $1,169 Mn in 2030 with a CAGR of 7.1% for the forecasted year 2022-30. The rising prevalence of cancer and supportive government policies to promote immunotherapy options in Indonesia is responsible for the expansion of the market. The Indonesia cancer immunotherapy market is segmented by type, application, and end user. Asa Rén, Cordlife, and Bristol-Myers Squibb are the major players in the Indonesia cancer immunotherapy market.
Indonesia Radiotherapy Market Analysis
By 2030, it is anticipated that the Indonesia Radiotherapy Market will reach a value of $xx Mn from $41 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Indonesia is dominated by a few domestic players such as Viet Medical Equipment, Shimadzu Indonesia, and Varian Medical Systems. The radiotherapy market in Indonesia is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Indonesia Radiotherapy is increasing on account of the rise in cancer cases in the country.
Indonesia Home Healthcare Market Analysis
Indonesia's home healthcare market was valued at $2.18 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.93% from 2022-30 and will reach $4 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, The increased prevalence of chronic ailments. The market is segmented by equipment outlook and by services. Some key players in this market are Noble Care, Allium Healthcare, Econ Home Care, Elderly Care, and PT. Medikabina Sejahtera home healthcare.
Indonesia Oncology Clinical Trials Market Analysis
Indonesia's oncology clinical trials market is projected to grow from $75.9 Mn in 2022 to $116.5 Mn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. The market will be driven by the increasing need for innovative and effective therapies with the rising incidence of cancers and increased investments in healthcare infrastructure. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International AG & Kalbe Farma.
Indonesia Diabetes Therapeutics Market Analysis
Indonesia's diabetes therapeutics market is expected to grow from $863 Mn in 2022 to $1,811 Mn in 2030 with a CAGR of 9.7% for the forecasted year 2022-2030. The increasing awareness regarding the consequences of diabetes in Indonesia as well as supportive government policies to promote diabetes awareness in Indonesia are the major market drivers. The Indonesia diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Tatarasa, Dexa Group, and GlaxoSmithKline are the major players in the Indonesia diabetes therapeutics market.
Indonesia Anti Aging Therapeutics Market Analysis
Indonesia's anti-ageing therapeutics market is projected to grow from $4 Mn in 2022 to $12 Mn in 2030 with a CAGR of 16.53% for 2022-2030. The market expansion is attributed to the growing elderly population and supportive government policies in Indonesia. The Indonesia anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and distribution channel. Some of the key players in the market include Asa Rén, PT Mitra Asiatek Biosensor, and Procter & Gamble.
Indonesia Oncology Drugs Market Analysis
By 2030, it is anticipated that the Indonesia oncology drugs market will reach a value of $xx Bn from $1.18 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The oncology drug market in Indonesia is dominated by a few large pharmaceutical companies such as Bio Farma, Innogene by Kalbe Farma and Takeda Pharma. The oncology market in Indonesia is segmented into different therapeutic areas and different treatment types. The major factors affecting the Indonesian oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Indonesia.
Indonesia Vaccines Market Analysis
This report presents a strategic analysis of the Indonesia Vaccines Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Vaccines Market, offering unmatched value, accuracy and expert insights.
Indonesia Diabetes Devices Market Analysis
Indonesia's Diabetes Devices Market is expected to witness growth from $136 Mn in 2022 to $238 Mn in 2030 with a CAGR of 7.20% for the forecasted year 2022-2030. With roughly 10 million sufferers, diabetes is a condition that is very common in Indonesia. This indicates a sizable market for diabetes devices. The market is segmented by type and by the end user. Some key players in this market include PT. Ravindra Putrapratama, Tawada Healthcare, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Indonesia Telemedicine Market Analysis
This report presents a strategic analysis of the Indonesia Telemedicine Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Indonesia Telemedicine Market, offering unmatched value, accuracy and expert insights.
Indonesia In Vitro Fertilisation (IVF) Service Market Analysis
This report presents a strategic analysis of Indonesia's In Vitro Fertilisation (IVF) Service Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about Indonesia In Vitro Fertilisation (IVF) Service Market, offering unmatched value, accuracy and expert insights.
Indonesia Cardiac Surgery Instruments Market Analysis
Indonesia's Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 6.60% for the forecasted year 2022-2030. Heart disease is the leading cause of death in Indonesia, accounting for 28.56% of all fatalities, which is driving up demand for cardiac surgery equipment in the Indonesian healthcare market. The market is segmented by type, application and by the end user. Some key players in this market include PT. Oneject Indonesia, PT. Provital Perdana, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Indonesia Artificial Intelligence (AI) in Diagnostics Market Analysis
Indonesia's Artificial Intelligence (AI) in the diagnostics market is projected to grow from $6.0 Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022-2030. The market will be driven by rising privatization in Indonesia and increasing adoption of AI technology in the country. The market is segmented by component & by diagnosis. Some of the major players include IBM Watson Health, Siemens Healthineers & Philips Healthcare.
Indonesia 3D Imaging Market Analysis
Indonesia's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by the government's increasing focus on the healthcare sector and the rising number of private hospitals and clinics. The market is segmented by product, by application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.
Indonesia ECG Equipments Market Analysis
The Indonesia ECG Equipment Market is expected to witness growth from $53 Mn in 2022 to $94 Mn in 2030 with a CAGR of 7.30% for the forecasted year 2022-2030. Indonesia is seeing an increase in the number of cardiac illnesses, which is driving up demand for ECG equipment for monitoring and diagnostics. The market is segmented by product type and by the end user. Some key players in this market include Graha Ismaya, PT Urogen Advanced Solutions, PT Transmedic, Johnson & Johnson, Philipps Healthcare, Medtronic, GE Healthcare, and Nihon Kohden.
Indonesia Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia liver cancer therapeutics market will reach a value of $64.3 Mn from $17.58 Mn in 2022, growing at a CAGR of 17.6% during 2022-30. The liver cancer therapeutics market in Indonesia is dominated by a few domestic pharmaceutical companies such as Chugai Pharmaceutical, Taiho Pharmaceutical, and Eisai. The liver cancer therapeutics market in Indonesia is segmented into different types of cancer and different therapy type. Some of the major factors affecting this market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
Indonesia Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Lung Cancer Therapeutics Market will reach a value of $334 Mn from $179 Mn in 2022, growing at a CAGR of 8.1% during 2022-2030. The Lung Cancer Therapeutics Market in Indonesia is dominated by a few domestic pharmaceutical companies such as Dexa Medica, Kalbe Farma, and Phapros. The Lung Cancer Therapeutics Market in Indonesia is segmented into different types of cancer and different therapy type. Some of the major factors affecting the Indonesia lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
Indonesia Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Oncology Therapeutics Market will reach a value of $2.1 Bn from $1.1 Bn in 2022, growing at a CAGR of 8.4% during 2022-2030. The Oncology Therapeutics Market in Indonesia is dominated by a few domestic pharmaceutical companies such as Dexa Medica, Kalbe Farma, and Tempo Scan Pacific. The Oncology Therapeutics Market in Indonesia is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Indonesia Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Indonesia Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Indonesia Liver Disease Therapeutics market will reach a value of $216 Mn from $139 Mn in 2022, growing at a CAGR of 5.7% during 2022-2030. Liver Disease Therapeutics in Indonesia are dominated by a few domestic pharmaceutical companies such as Kalbe Farma, Dexa Medica, and Combiphar. The Liver Disease Therapeutics market in Indonesia is segmented into different types of disease and different therapy types. Some of the major factors affecting the Indonesia Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Indonesia Biomaterials in Healthcare Market Analysis
The Indonesia Biomaterials in Healthcare Market is expected to witness growth from $938 Mn in 2022 to $2528 Mn in 2030 with a CAGR of 13.20% for the forecasted year 2022-2030. As Indonesia's economy expands, disposable incomes rise and people are starting to care more about their health. This will probably increase demand for healthcare services and items, as well as for the biomaterials used in medical equipment and other applications. The market is segmented by type and by application. Some key players in this market include: PT Dharma Medipro, PT Citra Medika Lestari, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.